Prognostic factors for long‐term infliximab treatment in Crohn's disease patients: a 20‐year single centre experience

Abstract

This study identified several easy to obtain predictors of infliximab failure in patients with Crohn's disease, and these are in line with previous reports. Those with a high-risk profile for infliximab failure in whom infliximab initiation is considered, should be treated as early as possible making use of therapeutic drug monitoring.